Skip to main content

$0.180 0.015 (9.09%)

High

$0.18

Low

$0.17

Trades

42

Turnover

$91,156

Volume

530,592
30 June 2023 at 3:58pm
Register to track NUH and receive email alerts.
Subject
NUH Ann: Suspension From Official Quotation

NUH Ann: Trading Halt

NUH Ann: Notification regarding unquoted securities - NUH

NUH Ann: Agreement for the Sale of Non-Core Mining Royalty

NUH Ann: Appendix 4C Quarter Ended 31 March 2022 - Amended

NUH Ann: NUH Announces New CEO and Roth Capital to Explore US Listing

NUH Ann: Presentation - 2022FY Q3 Results

NUH Ann: Quarterly Activities Report and Appendix 4C

NUH Ann: Notification of cessation of securities - NUH

NUH Ann: Notification regarding unquoted securities - NUH

NUH Ann: Results of General Meeting

NUH Ann: Section 708A(5)(e) Notice

NUH Ann: Application for quotation of securities - NUH

NUH Ann: Nuheara Enters Worldwide Trademark License Agreement With HP

NUH Ann: Nuheara Submits 510(k) for U.S. FDA Clearance

NUH Ann: Consolidation/Split - NUH

NUH Ann: Letter to Shareholders - Notice of General Meeting

NUH Ann: Notice of General Meeting/Proxy Form

NUH Ann: Notification of cessation of securities - NUH

NUH Ann: H1 FY22 - Nuheara Well Placed to Grow

NUH Ann: Appendix 4D and Half Year Financial Report

NUH Ann: Nuheara Expands in US to Capture Regulated Hearing Market

NUH Ann: Section 708A(5)(e) Notice

NUH Ann: Application for quotation of securities - NUH

NUH Ann: Presentation - 2022FY Q2 Results

NUH Ann: Clinical Trial Validates Nuheara Self-Fitted Hearing Aids

NUH Ann: Quarterly Activities Report and Appendix 4C

NUH Ann: Q2 FY22 Business Update and Investor Briefing Details

NUH Ann: Change of Director's Interest Notice x 4

NUH Ann: Application for quotation of securities - NUH

NUH Ann: Nuheara Completes Share Purchase Plan

NUH Ann: Nuheara Clinical Trial and FDA 510(K) Pathway Update

NUH Ann: Notification regarding unquoted securities - NUH

NUH Ann: Notification of cessation of securities - NUH

NUH Ann: Ceasing to be a substantial holder

NUH Ann: Share Purchase Plan Offer Document

NUH Ann: Section 708A(5)(e) Notice

NUH Ann: Application for quotation of securities - NUH

NUH Ann: Section 708A(5)(e) Notice

NUH Ann: Application for quotation of securities - NUH

NUH Ann: Nuheara Undertakes Capital Raising to Support Growth

NUH Ann: Proposed issue of securities - NUH

NUH Ann: Presentation - Company Update

NUH Ann: Nuheara Secures Global Supply Agreement With Sonova

NUH Ann: Nuheara Receives $1.74 Million R&D Tax Cash Rebate

NUH Ann: Nuheara Clinical Trial and FDA 510(K) Pathway Update

NUH Ann: Change in substantial holding

NUH Ann: Nuheara to Present at TechOpps 2021 Virtual Conference

NUH Ann: NUH Appointed Service Provider to Fed Govt Hearing Program

NUH Ann: 2022FY Q1 Results

Register to track NUH and receive email alerts.

Similar Companies

QFY
SF1
WBT